Remove Echocardiogram Remove Hospital Remove Ultrasound
article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. Lantheus announced that the U.S.

article thumbnail

UltraSight Expands Access to Cardiac Monitoring with AI

DAIC

11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM). tim.hodson Tue, 02/18/2025 - 16:17 Feb.

article thumbnail

Latest echocardiogram guidelines recommend ultrasound contrast agent

Becker's Hospital Review - Cardiology

"Discover the latest guidelines from the European Society of Cardiology for managing chronic coronary syndromes, including the strong recommendation for using u

article thumbnail

Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy

DAIC

A study featuring Fujifilm’s OPIE Transducer highlights that the system provides established imaging to aid in septal myectomy procedures compared to TEE and transthoracic echocardiogram (TTE). The OPIE transducer is compatible with Fujifilm’s premium ultrasound system, the ARIETTA Precision.

article thumbnail

Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

DAIC

Developed at Children’s National Hospital and detailed in the latest edition of the Journal of the American Heart Association , the new AI system combines the power of novel ultrasound probes with portable electronic devices installed with algorithms capable of diagnosing RHD on echocardiogram.

article thumbnail

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

DAIC

Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, AI-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform. We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S.

article thumbnail

Transient STEMI, serial ECGs prehospital to hospital, all troponins negative (less than 0.04 ng/ml)

Dr. Smith's ECG Blog

1.196 x STE60 in V3 in mm) + (0.059 x computerized QTc) - (0.326 x RA in V4 in mm) Third, one can do an immediate cardiac ultrasound. A bedside ultrasound was done by an emergency physician and simultaneously read by a cardiologist. greater than 23.4 is likely anterior STEMI). LV aneurysm is very different for inferior vs. anterior MI.

STEMI 52